SREBF1 and metabolic dysfunction-associated steatotic liver disease: To further confirm the hepatic lipid burden in our NAFLD model with a decrease in its oxidation, we performed qualitative real-time PCR for analyzing the hepatic expression of lipid metabolic genes including SREBP-1-c and PPAR-α.